Submissions from 2011
Science of safety topic coverage in experiential education in US and Taiwan colleges and schools of pharmacy, Derek H. Tang, Terri L. Warholak, Marion K. Slack, Daniel C. Malone, and Churn Shiouh Gau
Assessment tool for pharmacy drug-drug interaction software, Terri L. Warholak, Lisa E. Hines, Kim R. Saverno, Amy J. Grizzle, and Daniel C. Malone
Medical, nursing, and pharmacy students' ability to recognize potential drug-drug interactions: A comparison of healthcare professional students, Terri L. Warholak, Lisa E. Hines, Mi Chi Song, Austin Gessay, J. Michael Menke, Duane Sherrill, Sally Reel, John E. Murphy, and Daniel C. Malone
Perspectives on educating pharmacy students about the science of safety, Terri L. Warholak, David A. Holdford, Donna West, Danielle L. Debake, John P. Bentley, Daniel C. Malone, and John E. Murphy
A drug-drug interaction knowledge assessment instrument for health professional students: A Rasch analysis of validity evidence, Terri L. Warholak, J. Michael Menke, Lisa E. Hines, John E. Murphy, Sally Reel, and Daniel C. Malone
Results of the arizona medicaid health information technology pharmacy focus groups, Terri L. Warholak, Anita Murcko, Megan McKee, and Terry Urbine
Faculty perceptions of the educating pharmacy students to improve quality (EPIQ) program, Terri L. Warholak, Marwa Noureldin, Donna West, and David Holdford
Medication error identification rates by pharmacy, medical, and nursing students, Terri L. Warholak, Caryn Queiruga, Rebecca Roush, and Hanna Phan
Educating for safety the science of safety curriculum in US colleges and schools of pharmacy, Donna West-Strum, Ram Basak, John P. Bentley, David A. Holdford, Terri L. Warholak, Daniel C. Malone, and John E. Murphy
The science of safety curriculum in US colleges and schools of pharmacy., Donna West-Strum, Ram Basak, John P. Bentley, David A. Holdford, Terri L. Warholak, Daniel C. Malone, and John E. Murphy
Submissions from 2010
Optimizing sustained use of sedation in mechanically ventilated patients: Focus on safety, Heather M. Arnold, James M. Hollands, Lee P. SkrupkY., and Scott T. Micek
Hospital resource utilization and costs of inappropriate treatment of candidemia, Heather M. Arnold, Scott T. Micek, Andrew F. Shorr, Marya D. Zilberberg, Andrew J. Labelle, Smita Kothari, and Marin H. Kollef
Impact of online lecture-capture on student outcomes in a therapeutics course, Suzanne G. Bollmeier, Philip J. Wenger, and Alicia B. Forinash
Rx product news profile: A closer look at new FDA actions: Bristol-Myers Squibb's and AstraZeneca's Onglyza, Laura Moretti Challen and Trang Ho
Characteristics of patients with morbid obesity at an academic medical center, Eli N. Deal, James M. Hollands, Richard M. Reichley, and Scott T. Micek
Nicotine replacement therapy effect on pregnancy outcomes, Alicia B. Forinash, Jamie M. Pitlick, Kylie Clark, and Valerie Alstat
Differences in self-reported academically dishonest and nondishonest pharmacy students when rating professional dishonesty scenarios, Alicia B. Forinash, W. Thomas Smith, Claude J. Gaebelein, and Jeffrey Garavaglia
Administering intravenous immune globulin for a patient with clostridium difficile infection and acute renal failure, Jennifer S. Hardesty and Paul Juang
Recurrent ochrobactrum anthropi, treatment, and clinical relevance, Jennifer S. Hardesty and Paul Juang
Gamma-glutamyl carboxylase and its influence on warfarin dose, Cristi R. King, Elena Deych, Paul Milligan, Charles Eby, Petra Lenzini, Gloria Grice, Rhonda M. Porche-Sorbet, Paul M. Ridker, and Brian F. Gage
A magic bullet for sepsis: Getting back to the basics, Marin H. Kollef and Scott T. Micek
Using protocols to improve patient outcomes in the intensive care unit: Focus on mechanical ventilation and sepsis, Marin H. Kollef and Scott T. Micek
A comparison of culture-positive and culture-negative health-care- associated pneumonia, Andrew J. Labelle, Heather Arnold, Richard M. Reichley, Scott T. Micek, and Marin H. Kollef
Integration of genetic, clinical, and INR data to refine warfarin dosing, P. Lenzini, M. Wadelius, S. Kimmel, J. L. Anderson, A. L. Jorgensen, M. Pirmohamed, M. D. Caldwell, N. Limdi, J. K. Burmester, M. B. Dowd, P. Ngchaisuksiri, A. R. Bss, J. Chen, N. Eriksson, A. Rane, J. D. Lindh, J. F. Carlquist, B. D. Horne, G. Grice, P. E. Milligan, C. Eby, J. Shin, H. Kim, D. Kurnik, C. M. Stein, G. McMillin, R. C. Pendleton, R. L. Berg, P. Deloukas, and B. F. Gage
Antimicrobial resistance: Consideration as an adverse drug event, Steven J. Martin, Scott T. Micek, and G. Christopher Wood
Bacteremia increases the risk of death among patients with soft-tissue infections, Scott T. Micek, Alex P. Hoban, Victor Pham, Joshua A. Doherty, Marya D. Zilberberg, Andrew F. Shorr, and Marin H. Kollef
Sepsis bundles: Just do it, Scott T. Micek and Amber M. Sawyer
Current concepts in the prevention and treatment of ventilator-associated pneumonia, Scott T. Micek and Lee P. Skrupky
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to gram-negative bacteria: A retrospective analysis, Scott T. Micek, Emily C. Welch, Junaid Khan, Mubashir Pervez, Joshua A. Doherty, Richard M. Reichley, and Marin H. Kollef
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis, Julie A. Murphy, Jacklyn A. Harris, and Andrew J. Crannage
A Prospective Observational Study of Medication Errors in a Tertiary Care Emergency Department, Asad E. Patanwala, Terri L. Warholak, Arthur B. Sanders, and Brian L. Erstad
Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment, Kiran V. Sarikonda, Scott T. Micek, Joshua A. Doherty, Richard M. Reichley, David Warren, and Marin H. Kollef
Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia, Lee P. Skrupky, Jennifer R. Smith, Eli N. Deal, Heather Arnold, James M. Hollands, Emily J. Martinez, and Scott T. Micek
Early prediction of septic shock in hospitalized patients, Steven W. Thiel, Jamie M. Rosini, William Shannon, Joshua A. Doherty, Scott T. Micek, and Marin H. Kollef
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans, D. Voora, D. C. Koboldt, C. R. King, P. A. Lenzini, C. S. Eby, R. Porche-Sorbet, E. Deych, M. Crankshaw, P. E. Milligan, H. L. McLeod, S. R. Patel, L. H. Cavallari, P. M. Ridker, G. R. Grice, R. D. Miller, and B. F. Gage
Assessing student perceived outcomes for a Methods Television (MTV) video project in a research methodology class, Terri L. Warholak, Adrienne M. Gilligan, Jason T. Hurwitz, Marion Slack, Christina A. Spivey, and Marie Chisholm-Burns
The educating pharmacy students and pharmacists to improve quality program: Tool for pharmacy practice, Terri L. Warholak, Donna West, and David A. Holdford
The prophylactic role for the human papillomavirus quadrivalent vaccine in males, Abigail M. Yancey, Jamie M. Pitlick, and Alicia B. Forinash
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: A retrospective cohort study, Marya D. Zilberberg, Marin H. Kollef, Heather Arnold, Andrew Labelle, Scott T. Micek, Smita Kothari, and Andrew F. Shorr
Hospitalizations with healthcare-associated complicated skin and skin structure infections: Impact of inappropriate empiric therapy on outcomes, Marya D. Zilberberg, Andrew F. Shorr, Scott T. Micek, Joyce Chen, Andrew M. Ramsey, Alex P. Hoban, Victor Pham, Joshua A. Doherty, Samir H. Mody, and Marin H. Kollef
Submissions from 2009
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study, Eli N. Deal, Scott T. Micek, Richard M. Reichley, and David J. Ritchie
International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic, Brooke L. Griffin, Jill S. Burkiewicz, Laura R. Peppers, and Terri L. Warholak
Pharmacogenomics of warfarin: Uncovering a piece of the warfarin mystery, Michael P. Gulseth, Gloria R. Grice, and William E. Dager
Preface, Marin H. Kollef and Scott T. Micek
Levetiracetam use in pregnancy, Brian Longo, Alicia B. Forinash, and Julie A. Murphy
Independent community pharmacists' perspectives on compounding in contemporary pharmacy education, Kathleen S. Martin, Timothy B. McPherson, Patrick E. Fontane, Tricia Berry, Rasma Chereson, and Rhonda Bilger
The Management of Severe Sepsis and Septic Shock, Matthew R. Morrell, Scott T. Micek, and Marin H. Kollef
The importance of fluid management in acute lung injury secondary to septic shock, Claire V. Murphy, Garrett E. Schramm, Joshua A. Doherty, Richard M. Reichley, Ognjen Gajic, Bekele Afessa, Scott T. Micek, and Marin H. Kollef
New antibiotics for healthcare-associated pneumonia, Elizabeth A. Neuner, David J. Ritchie, and Scott T. Micek
Use of low-molecular-weight heparin for the treatment of venous thromboembolism in patients with cancer: A review of the literature, Jamie M. Pitlick, Andrew J. Crannage, and Julie A. Murphy
Adding diagnosis codes to prescriptions: Lessons learned from a quality improvement project, Ankur Ramesh Shah, Mark D. Boesen, Kimberly D. Harris-Salamone, and Terri L. Warholak
Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit, Lee P. Skrupky, Scott T. Micek, and Marin H. Kollef
Evaluation of risk factors and health outcomes among persons with asthma, Karen Smith, Terri Warholak, Edward Armstrong, Marc Leib, Rick Rehfeld, and Daniel Malone
Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis, Steven W. Thiel, Muhammad F. Asghar, Scott T. Micek, Richard M. Reichley, Joshua A. Doherty, and Marin H. Kollef
Preceptor perceptions of pharmacy student team quality assurance projects, Terri L. Warholak
An exploratory comparison of medication lists at hospital admission with administrative database records, Terri L. Warholak, Matthew McCulloch, Alysson Baumgart, Mindy Smith, William Fink, and William Fritz
Analysis of community chain pharmacists' interventions on electronic prescriptions, Terri L. Warholak and Michael T. Rupp
Clostridium difficile-associated disease and mortality among the elderly critically ill, Marya D. Zilberberg, Andrew F. Shorr, Scott T. Micek, Joshua A. Doherty, and Marin H. Kollef
Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: Implications of healthcare-associated infection risk factors, Marya D. Zilberberg, Andrew F. Shorr, Scott T. Micek, Alex P. Hoban, Victor Pham, Joshua A. Doherty, Andrew M. Ramsey, and Marin H. Kollef
Submissions from 2008
Clinical pharmacist competencies, John M. Burke, William A. Miller, Anne P. Spencer, Christopher W. Crank, Laura Adkins, Karen E. Bertch, Dominic P. Ragucci, William E. Smith, and Amy W. Valley
Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease, Andrea M. Chen, Suzanne G. Bollmeier, and Patrick M. Finnegan
Role of corticosteroids in the management of acute respiratory distress syndrome, Eli N. Deal, James M. Hollands, Garrett E. Schramm, and Scott T. Micek
Corrigendum: Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin (Clinical Pharmacology Therapeutics (2008) 84, (326-331) DOI: 10.1038/clpt.2008.10), B. F. Gage, C. Eby, J. A. Johnson, E. Deych, M. J. Rieder, P. M. Ridker, P. E. Milligan, G. Grice, P. Lenzini, A. E. Rettie, C. L. Aquilante, L. Grosso, S. Marsh, T. Langaee, L. E. Farnett, D. Voora, D. L. Veenstra, R. J. Glynn, A. Barrett, and H. L. McLeod
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin, B. F. Gage, C. Eby, J. A. Johnson, E. Deych, M. J. Rieder, P. M. Ridker, P. E. Milligan, G. Grice, P. Lenzini, A. E. Rettie, C. L. Aquilante, L. Grosso, S. Marsh, T. Langaee, L. E. Farnett, D. Voora, D. L. Veenstra, R. J. Glynn, A. Barrett, and H. L. McLeod
Periprocedural anticoagulation management in orthopedic patients: Overview and description of a program utilizing pharmacogenetics, Gloria R. Grice, Douglas Laramie, and Douglas C. Anderson
Gabapentin as a potential option for treatment of sciatica, Gloria R. Grice and Marsha K. Mertens
Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive [7], G. R. Grice, P. E. Milligan, C. Eby, and Brian F. Gage
The importance of early treatment with doxycycline in human ehrlichiosis, Brian J. Hamburg, Gregory A. Storch, Scott T. Micek, and Marin H. Kollef
An evaluation of the validity of inferences made from 3 diabetes assessment instruments: A Rasch analysis, Lisa Izzo Handley, Terri L. Warholak Jackson, and Terrence R. Jackson
Developing a business-practice model for pharmacy services in ambulatory settings., Ila M. Harris, E. Baker, Tricia M. Berry, Mary Ann Halloran, Kathleen Lindauer, Kelly R. Ragucci, Melissa Somma McGivney, A. Thomas Taylor, and Stuart T. Haines
The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia, Katherine E. Kollef, Richard M. Reichley, Scott T. Micek, and Marin H. Kollef
Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria, Katherine E. Kollef, Garrett E. Schramm, Angela R. Wills, Richard M. Reichley, Scott T. Micek, and Marin H. Kollef
Health care-associated pneumonia (HCAP): A critical appraisal to improve identification, management, and outcomes-proceedings of the HCAP summit, Marin H. Kollef, Lee E. Morrow, Robert P. Baughman, Donald E. Craven, John E. McGowan, Scott T. Micek, Michael S. Niederman, David Ost, David L. Paterson, and John Segreti
Health care-associated infection (HAI): A critical appraisal of the emerging threat - Proceedings of the HAI Summit, Marin H. Kollef, Lena M. Napolitano, Joseph S. Solomkin, Richard G. Wunderink, In Gyu Bae, Vance G. Fowler, Robert A. Balk, Dennis L. Stevens, James J. Rahal, Andrew F. Shorr, Peter K. Linden, and Scott T. Micek
Treatment-related risk factors for hospital mortality in Candida bloodstream infections, Andrew J. Labelle, Scott T. Micek, Nareg Roubinian, and Marin H. Kollef
Impact of the Career Explorers program on high school students' perceptions of the pharmacy profession., Sarah M. Langridge, Sheri L. Stensland, Terri L. Warholak, and Lisa Mattingly
Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients, P. A. Lenzini, G. R. Grice, P. E. Milligan, M. B. Dowd, S. Subherwal, E. Deych, C. S. Eby, C. R. King, R. M. Porche-sorbet, C. V. Murphy, R. Marchand, E. A. Millican, R. L. Barrack, J. C. Clohisy, K. Kronquist, S. K. Gatchel, and Brian F. Gage
Response by the authors, Scott Micek
Evaluation of e-prescribing in chain community pharmacy: Best-practice recommendations, Michael T. Rupp and Terri L. Warholak
Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications, Andrew F. Shorr, Scott T. Micek, and Marin H. Kollef
Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia, Andrew F. Shorr, Marya D. Zilberberg, Scott T. Micek, and Marin H. Kollef
Evaluation of feeding intolerance in patients with pentobarbital-induced coma, Alison M. Stevens, Janine E. Then, Karen M. Frock, Bruce A. Crookes, Christopher Commichau, Brian T. Marden, Bonnie J. Beynnon, and Jill A. Rebuck
A Pharmacy Faculty Academy to foster professional growth and long-term retention of junior faculty members., Charles T. Taylor and Tricia M. Berry
Dosing anticoagulant therapy with coumarin drugs: Is genotyping clinically useful? Yes, S. M. Thacker, G. R. Grice, P. E. Milligan, and Brian F. Gage
Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia*: A single-center experience, Marya D. Zilberberg, Andrew F. Shorr, Scott T. Micek, Samir H. Mody, and Marin H. Kollef
Submissions from 2007
Impact of a community pharmacy experience on medical residents' understanding of the role of a community pharmacist, Tricia M. Berry, Julie A. Murphy, and Audrey K. Montooth
Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii, Eli N. Deal, Scott T. Micek, David J. Ritchie, Richard M. Reichley, W. Michael Dunne, and Marin H. Kollef
Early appropriate empiric therapy and antimicrobial de-escalation, James M. Hollands, Scott T. Micek, Peggy S. McKinnon, and Marin H. Kollef
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia, Meghan N. Jeffres, Warren Isakow, Joshua A. Doherty, Scott T. Micek, and Marin H. Kollef
Update on new antifungal therapy, Paul Juang
Update on new antifungal therapy., Paul Juang
Enteral glutamine supplementation in critically ill patients with burn injuries: A retrospective case-control evaluation, Paul Juang, Douglas N. Fish, Rose Jung, and Robert MacLaren
Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea, Paul Juang, Susan J. Skledar, Nathalie K. Zgheib, David L. Paterson, Emanuel N. Vergis, William D. Shannon, Nicole T. Ansani, and Robert A. Branch
Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting, Claire Kenneally, Jamie M. Rosini, Lee P. Skrupky, Joshua A. Doherty, James M. Hollands, Emily Martinez, Wendi McKenzie, Theresa Murphy, Jennifer R. Smith, Scott T. Micek, and Marin H. Kollef
Optimal initial dose adjustment of warfarin in orthopedic patients, Petra A. Lenzini, Gloria R. Grice, Paul E. Milligan, Susan K. Gatchel, Elena Deych, Charles S. Eby, R. Stephen J. Burnett, John C. Clohisy, Robert L. Barrack, and Brian F. Gage
Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections, Scott T. Micek
Health care-associated pneumonia and community-acquired pneumonia: A single-center experience, Scott T. Micek, Katherine E. Kollef, Richard M. Reichley, Nareg Roubinian, and Marin H. Kollef
Early goal-directed therapy of septic shock: We honestly remain skeptical [23], Scott T. Micek and Marin H. Kollef
Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: An observational study, Scott T. Micek, Poorvi Shah, James M. Hollands, Rina A. Shah, William D. Shannon, and Marin H. Kollef
Using protocols to improve the outcomes of critically ill patients with infection: Focus on ventilator-associated pneumonia and severe sepsis, S. T. Micek and M. H. Kollef